This meeting took place in 2018



For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

Emerging Technologies in Vaccine Discovery and Development (J5)


Organizer(s) David Kaslow, Nicholas Jackson and Ann L. Lee
January 28—February 1, 2018
Fairmont Banff Springs • Banff, Alberta Canada
Discounted Abstract Deadline: Oct 4, 2017
Abstract Deadline: Nov 2, 2017
Scholarship Deadline: Oct 4, 2017
Discounted Registration Deadline: Dec 6, 2017

Sponsored by Astellas Pharma Inc., Moderna Therapeutics and Pfizer Inc.
Part of the Keystone Symposia Global Health Series, supported by the Bill & Melinda Gates Foundation


Summary of Meeting:
Immunization remains one of the most effective preventive public health measures, the indirect effects of which are considered a global public good with an impressive net return over costs. Vaccines have contributed to “final public good”: eradication of two viruses and regional elimination of a half dozen or more other pathogens. The development of new vaccines, therefore, would seem an obvious priority area for use-inspired and applied biomedical research, yet the endeavor has become increasingly more challenging. The “easy vaccines have been made” belief, crowded vaccine schedules, escalating costs of full vaccination programs (particularly in cost-sensitive Gavi-eligible countries), and platforms for maternal immunization and Public Health Emergencies of International Concern have all contributed to an urgent need for new or improved approaches to the discovery, development and delivery of vaccines, particularly those that are cheaper, simpler to manufacture, and more convenient to use. The aim of this symposium is to provide a comprehensive survey of emerging tools from the most upstream antigen/vaccine discovery, to active and passive immunization platforms, clinical trials, and manufacturing, formulation and delivery, the desired outcome of which is to provide a forum for an integrated discussion on how best to meet the increasing challenges faced by the scientific community’s efforts in new vaccine development. The Keystone Symposia conference on “Emerging Technologies in Vaccine Discovery and Development” has been specifically paired with the conference on “HIV Vaccines” since discovering, developing and delivering an effective HIV vaccine may be one that benefits most from novel technologies, including new tools in structural immunology and interrogating human immune responses.

View Meeting Program

Scholarships/Awards

Keystone Symposia Future of Science Fund Scholarship Recipients

Clare N. Burn
Albert Einstein College of Medicine, USA

Kevin E. Lindsay
Georgia Institute of Technology, USA

Keystone Symposia Global Health Travel Award Recipients, funded by the Bill & Melinda Gates Foundation
Funded by Keystone Symposia Global Health Travel Award Recipients, funded by the Bill & Melinda Gates Foundation

Mohd Anees Ahmed
National Institute of Immunology, India

Fausto Almeida
University of São Paulo, Brazil

Olorunsola Niyi Bankole
Diversay Solutions, Nigeria

Augusto Ernesto Bivona
Institute of Humoral Immunity Studies, Argentina

Dorcas Amara Gado
National Veterinary Research Institute, Nigeria

Shakila Harshavardhan
Madurai Kamaraj University, India

Mohammad Uzzal Hossain
National Institute of Biotechnology, Bangladesh

José Manuel Jaramillo Ortiz
Instituto Nacional de Tecnología Agropecuaria, Argentina

Eva Kisakye
Medical Research Council Uganda Research Unit, Uganda

Abdurehman Eshete Mohammed
Izmir Institute of Technology, Turkey

Florencia Muñoz Gonzalez
IDEHU-Universidad de Buenos Aires-CONICET, Argentina

Yewande Tolulope Nejo
University of Ibadan, Nigeria

Olukunle Oluwapamilerin Oluwasemowo
University of Ibadan, Nigeria

Poonam Salotra
National Institute of Pathology, India

Maria Victoria Sanchez
Institute of Medicine and Experimental Biology of Cuyo, Argentina

Alessandra Schanoski
Butantan Institute, Brazil

Rajgokul Kullampalayam Shanmugam
International Centre for Genetic Engineering and Biotechnology, India

Rahul Shukla
International Centre for Genetic Engineering and Biotechnology, India

Subhash Verma
CSK-Himachal Pradesh Agriculture University, India